Treatment of the jaundiced patient with breast carcinoma : Case report and alternate therapeutic strategiesGUREVICH, Irina; AKERLEY, Wallace.Cancer. 2001, Vol 91, Num 4, pp 660-663, issn 0008-543XArticle

A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysisNELSON, Richard E; STENEHJEM, David; AKERLEY, Wallace et al.Lung cancer. 2013, Vol 82, Num 3, pp 461-468, issn 0169-5002, 8 p.Article

The impact of a serum based proteomic mass spectrometry test on treatment recommendations in advanced non-small-cell lung cancerAKERLEY, Wallace L; NELSON, Richard E; COWIE, Robin H et al.Current medical research and opinion. 2013, Vol 29, Num 5, pp 517-525, issn 0300-7995, 9 p.Article

Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancerAKERLEY, Wallace; SAFRAN, Howard; ZANER, Ken et al.Cancer. 2006, Vol 107, Num 5, pp 1050-1054, issn 0008-543X, 5 p.Article

Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancerDONG WOOK KIM; SHYR, Yu; SHAKTOUR, Bashar et al.Lung cancer. 2005, Vol 50, Num 2, pp 235-245, issn 0169-5002, 11 p.Article

Small-Cell Carcinoma of the ProstateANKER, Christopher J; DECHET, Christopher; ISAAC, Jorge C et al.Journal of clinical oncology. 2008, Vol 26, Num 7, pp 1168-1171, issn 0732-183X, 4 p.Article

An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastasesSANDLER, Alan; HIRSH, Vera; RECK, Martin et al.Lung cancer. 2012, Vol 78, Num 1, pp 1-7, issn 0169-5002, 7 p.Article

A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving boneAKERLEY, Wallace; BUTERA, James; LEONE, Louis et al.Cancer. 2002, Vol 94, Num 6, pp 1654-1660, issn 0008-543XArticle

Weekly, high-dose paclitaxel in advanced lung carcinoma: A Phase II study with pharmacokinetics by the Cancer and Leukemia Group BAKERLEY, Wallace; HERNDON, James E; GREEN, Mark B et al.Cancer. 2003, Vol 97, Num 10, pp 2480-2486, issn 0008-543X, 7 p.Article

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer : Cancer and leukemia group BVOKES, Everett E; HERNDON, James E; KELLEY, Michael J et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1698-1704, issn 0732-183X, 7 p.Article

Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancerFANUCCHI, Michael P; FOSSELLA, Frank V; AKERLEY, Wallace et al.Journal of clinical oncology. 2006, Vol 24, Num 31, pp 5025-5033, issn 0732-183X, 9 p.Article

A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluationAKERLEY, Wallace; BOUCHER, Kenneth; RICH, Nathan et al.Lung cancer. 2013, Vol 79, Num 3, pp 307-311, issn 0169-5002, 5 p.Article

Improved Survival with Ipilimumab in Patients with Metastatic MelanomaHODI, F. Stephen; O'DAY, Steven J; AKERLEY, Wallace et al.The New England journal of medicine. 2010, Vol 363, Num 8, pp 711-723, issn 0028-4793, 13 p.Article

Safety of Bevacizumab in Patients With Non-Small-Cell Lung Cancer and Brain MetastasesSOCINSKI, Mark A; LANGER, Corey J; HUANG, Jane E et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5255-5261, issn 0732-183X, 7 p.Article

The Role of Intra-cerebrospinal Fluid Treatment and Prophylaxis in Patients With Solid TumorsSOFFIETTI, Riccardo; AKERLEY, Wallace; JENSEN, Randy L et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S55-S68, SUP2Conference Paper

Randomized Phase II Trial of Sorafenib with Temsirolimus or Tipifarnib in Untreated Metastatic Melanoma (S0438)MARGOLIN, Kim A; MOON, James; FLAHERTY, Lawrence E et al.Clinical cancer research (Print). 2012, Vol 18, Num 4, pp 1129-1137, issn 1078-0432, 9 p.Article

Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: Report from the Cancer and leukemia Group BBLACKSTOCK, A. William; HERNDON, James E; GREEN, Mark R et al.Journal of the National Cancer Institute. 2002, Vol 94, Num 4, pp 284-290, issn 0027-8874Article

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung CancerSEQUIST, Lecia V; VON PAWEL, Joachim; RAMLAU, Rodryg et al.Journal of clinical oncology. 2011, Vol 29, Num 24, pp 3307-3315, issn 0732-183X, 9 p.Article